XML 34 R5.htm IDEA: XBRL DOCUMENT v3.24.0.1
Consolidated Statements of Changes in Equity - CAD ($)
$ in Millions
Total
Preferred shares and other equity [Member]
Common shares [Member]
Shareholders and other equity holders retained earnings [Member]
Shareholders and other equity holders retained earnings [Member]
Opening Adjustment Of Financial Assets At Adoption Of IFRS 9 IFRS17 [Member]
Shareholders and other equity holders retained earnings [Member]
Opening Adjustment Of Insurance Contracts At Adoption Of IFRS17 [Member]
Contributed Surplus [Member]
Shareholders' accumulated other comprehensive income (loss) ("AOCI") [Member]
Shareholders' accumulated other comprehensive income (loss) ("AOCI") [Member]
Opening Adjustment Of Financial Assets At Adoption Of IFRS 9 IFRS17 [Member]
Shareholders' accumulated other comprehensive income (loss) ("AOCI") [Member]
Opening Adjustment Of Insurance Contracts At Adoption Of IFRS17 [Member]
Participating Policyholders' Equity [Member]
Participating Policyholders' Equity [Member]
Opening Adjustment Of Financial Assets At Adoption Of IFRS 9 IFRS17 [Member]
Participating Policyholders' Equity [Member]
Opening Adjustment Of Insurance Contracts At Adoption Of IFRS17 [Member]
Non-controlling Interests [Member]
Non-controlling Interests [Member]
Opening Adjustment Of Insurance Contracts At Adoption Of IFRS17 [Member]
Balance, beginning of year (Previously stated [member]) at Dec. 31, 2021       $ 23,492       $ 5,180     $ (1,233)     $ 1,694  
Balance, beginning of year (Increase (decrease) due to changes in accounting policy required by IFRSs [member]) at Dec. 31, 2021         $ (10,645) $ (3,191)     $ 16,916 $ (16,133)   $ 626 $ 707   $ (258)
Balance, beginning of year at Dec. 31, 2021   $ 6,381 $ 23,093 9,656     $ 262 5,963     100     1,436  
Issued (note 12)   1,000                          
Redeemed (note 12)   (711)                          
Issuance costs, net of tax   (10)                          
Exercise of stock options and deferred share units     23       (4)                
Stock option expense             5                
Net income (loss) attributed to shareholders and other equity holders       (1,933)                      
Common shares repurchased (note 12)     (938) (946)                      
Preferred share dividends and other equity distributions       (260)                      
Preferred shares redeemed (note 12)       (14)                      
Common share dividends       (2,513)                      
Change in unrealized foreign exchange gains (losses) on net foreign operations $ 1,755             1,340              
Net income (loss) attributed to participating policyholders (167)                   (167)        
Net income (loss) attributed to non-controlling interests 121                         121  
Other comprehensive income (loss) attributed to policyholders and non-controlling interests                     (10)     (104)  
Contributions (distributions and acquisition), net                           (26)  
Acquisition of non-controlling interest       (43)     (25)                
Other changes in OCI attributed to shareholders and other equity holders               177              
Change in unrealized gains (losses) on fair value through OCI investments               (42,407)              
Changes in insurance / reinsurance finance income (expenses)               48,780              
Balance, end of year (Previously stated [member]) at Dec. 31, 2022       3,947       13,853     (77)     1,427  
Balance, end of year (Increase (decrease) due to changes in accounting policy required by IFRSs [member]) at Dec. 31, 2022         $ (409)       $ 408            
Balance, end of year at Dec. 31, 2022 48,226 6,660 22,178 3,538     238 14,261     (77)     1,427  
Total shareholders' and other equity, end of year 46,876                            
Issued (note 12)   0                          
Exercise of stock options and deferred share units     94       (18)                
Stock option expense 2                            
Net income (loss) attributed to shareholders and other equity holders       5,103                      
Common shares repurchased (note 12)     (745) (850)                      
Preferred share dividends and other equity distributions       (303)                      
Common share dividends       (2,669)                      
Change in unrealized foreign exchange gains (losses) on net foreign operations (1,301)             (1,117)              
Net income (loss) attributed to participating policyholders 360                   360        
Net income (loss) attributed to non-controlling interests 144                         144  
Other comprehensive income (loss) attributed to policyholders and non-controlling interests                     (26)     (126)  
Contributions (distributions and acquisition), net                           (14)  
Other changes in OCI attributed to shareholders and other equity holders               (34)              
Change in unrealized gains (losses) on fair value through OCI investments               7,923              
Changes in insurance / reinsurance finance income (expenses)               (7,222)              
Balance, end of year at Dec. 31, 2023 48,727 $ 6,660 $ 21,527 $ 4,819     $ 222 $ 13,811     $ 257     $ 1,431  
Total shareholders' and other equity, end of year $ 47,039